Alloy vs Velvet Rx
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
Velvet Rx
Best for cash-pay patients comfortable with a compounded-GLP-1 telehealth model who prioritize three publicly-listed SKUs and bundled shipping over LegitScript / NABP certification, named pharmacy partner, or per-state availability verificationStarting at $139/mo
Side-by-Side Comparison
| Feature | Alloy | Velvet Rx |
|---|---|---|
| Overall Score | ✓7.4/10 | 6.6/10 |
| Starting Price | ✓$80/mo | $139/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.3 ★ /5 |
| Features | 8 features | 8 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | ✓ Yes |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
Velvet Rx
Pros
- ✓Publicly-disclosed pricing across 3 SKUs (semaglutide injection $299, tirzepatide injection $359, Oral GLP-1 $349) — uncommon transparency in the compounded telehealth segment
- ✓First-month promo pricing displayed verbatim on home: $139 sema / $199 tirz / $189 oral
- ✓Doctor consult, prescription, 4 weeks of medication, AND free 1-2 day shipping all included in single monthly price (verbatim: 'Same price, every dose. No hidden fees')
- ✓FSA / HSA eligibility claimed verbatim on the home
- ✓Three modalities under one roof: injectable sema, injectable tirz, and an oral GLP-1 option
- ✓No insurance accepted — fully cash-pay model with no membership fee disclosed
Cons
- ✗Oral GLP-1 SKU does NOT name the specific drug (Rybelsus? Foundayo? compounded oral semaglutide? — not disclosed) — material transparency gap given the three are clinically distinct (Rybelsus is T2D-indicated only, Foundayo is FDA-approved for chronic weight management, compounded oral has unsettled regulatory status)
- ✗No LegitScript Certified or NABP .pharmacy seal displayed on home or footer
- ✗No legal entity name disclosed publicly (footer reads only 'Copyright © 2025 VelvetRx')
- ✗No physical address disclosed publicly
- ✗No partner pharmacy named — does NOT disclose which 503A or 503B compounding pharmacy fills prescriptions
- ✗States available NOT enumerated — no state-by-state availability disclosure
- ✗Pricing display has internal inconsistency: hero shows '$299 $139 today' for sema; pricing card adds 'Save $60 instantly on your first month, then $100 off each month' which would imply $239 first / $199 ongoing — different math than the headline $139
- ✗Marketing claims include unverifiable percentages ('92% of patients are on track by month one,' '15% average body weight loss in first 90 days,' '9/10 patients say it's the most effective treatment they've ever tried') with no cited methodology, sample size, or independent audit
- ✗No FDA warning letters found for 'Velvet Rx' or 'VelvetRx' in the FDA warning-letter database as of 2026-05-10 — but this absence is not affirmative evidence of pharmacy quality
Our Verdict
Alloy edges out Velvet Rx with a higher overall score of 7.4/10 and is particularly strong for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory. Velvet Rx remains a solid alternative, especially if you're looking for cash-pay patients comfortable with a compounded-GLP-1 telehealth model who prioritize three publicly-listed SKUs and bundled shipping over LegitScript / NABP certification, named pharmacy partner, or per-state availability verification.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.